sciensano.be
Published on sciensano.be (https://www.sciensano.be)

Home > Biblio > Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.

Health and disease monitoring  

Peer reviewed scientific article

English

SCIENSANO

Authors

Ariƫn, Kevin K [1]

Keywords

    Abstract:

    We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.
    Read more

    Abstract

    We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult individuals. Our observations support the rapid administration of a booster vaccine dose to prevent infection and disease caused by Omicron.

    Associated health topics:

    Health and disease monitoring [2]

    Source URL:https://www.sciensano.be/en/biblio/three-doses-bnt162b2-vaccine-confer-neutralising-antibody-capacity-against-sars-cov-2-omicron

    Links
    [1] https://www.sciensano.be/en/biblio?f%5Bauthor%5D=68628&f%5Bsearch%5D=Ari%C3%ABn%2C%20Kevin%20K [2] https://www.sciensano.be/en/health-topics/health-and-disease-monitoring